Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 200 member C (FAM200C) is a human protein encoded by the FAM200C gene, also known by aliases such as ZBED8, C5orf54, and Buster3. It is classified as a protein coding gene, with known localization to the nucleoplasm and suggested molecular features including a zinc finger BED domain, which typically mediates DNA binding or chromatin association[3][5]. The gene's function, biological pathways, involvement in disease, and role as a therapeutic target are currently uncharacterized in the literature and major databases[3][2]. There is no evidence it functions as an enzyme, receptor, transporter, or recognized therapeutic target. This protein should not be confused with FAM20C, a well-characterized secreted protein kinase implicated in multiple diseases, including cancer and abnormal mineralization[1]. As such, FAM200C (ZBED8) is not an established drug target, and some sources may incorrectly conflate it with FAM20C due to similar gene symbols or aliases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 200 member C (FAM200C).